T. Rowe Price Investment Management, Inc. 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-08 3:26 pm Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | T. Rowe Price Investment Management, Inc. | 6,605,780 10.100% | 3,369,185 (+104.10%) | Filing |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | T. Rowe Price Investment Management, Inc. | 3,236,595 5.900% | 3,236,595 (New Position) | Filing |